CVE-2025-40700: Reflected Cross-Site Scripting (XSS) in IDI Eikon's Governalia
CVE-2025-40700 is a medium-severity flaw (CVSS 6.1) affecting governalia. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Reflected Cross-Site Scripting (XSS) in IDI Eikon's Governalia. The vulnerability allows an attacker to execute JavaScript code in the victim's browser when a malicious URL with the 'q' parameter in '/search' is sent to them. This vulnerability can be exploited to steal sensitive information such as session cookies or to perform actions on behalf of the victim.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.2% (top 92%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2025-12-02 |
| Last modified | 2026-10-18 |
Last updated 2026-10-18 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2025-40700?
governalia: upgrade to 1274. Exact commands for each OS are on this page.
Is CVE-2025-40700 being exploited?
CVE-2025-40700 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2025-40700 affect?
CVE-2025-40700 affects governalia. Severity is medium (CVSS 6.1). Reflected Cross-Site Scripting (XSS) in IDI Eikon's Governalia. The vulnerability allows an attacker to execute JavaScript code in the victim's browser when a malicious URL with the 'q' parameter in '/search' is sent to them. This vulnerabi
How urgent is CVE-2025-40700?
Priority 23/100. No elevated risk signals yet.